Cenersen clinical trials
Also written EL625.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses cenersen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Studies
Open first, then newest update. How each study uses cenersen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)TerminatedPhase 1Eleos, Inc.NCT02243124Written as cenersen
- Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction CourseWithdrawnPhase 2Eleos, Inc.NCT00967512Written as cenersen
- EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedPhase 2David RizzieriNCT00636155Written as cenersen sodium
Given beside what is tested · 1 — cenersen is usual care or a partner of the new treatment
Codes
What other systems call cenersen · ClinicalTrials.gg INT005996
- UNII (FDA) K6KJ8AZ05FCENERSENOne source FDA
- NCI Thesaurus C37454CenersenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | K6KJ8AZ05F | CENERSEN | One source FDA |
| NCI Thesaurus | C37454 | Cenersen | One source FDA |
Also registered as cenersen sodium (UNII CI002S7WH8).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.